Literature DB >> 25976433

Disorders for which the allergist-immunologist is particularly well-qualified to treat.

Joseph A Bellanti, Russell A Settipane.   

Abstract

Mesh:

Year:  2015        PMID: 25976433      PMCID: PMC4404428          DOI: 10.2500/aap.2015.36.3855

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


× No keyword cloud information.
  28 in total

1.  A 60-year-old woman with recurrent episodes of flushing, urticaria, and angioedema.

Authors:  Sheenal V Patel; James L Baldwin
Journal:  Allergy Asthma Proc       Date:  2015 May-Jun       Impact factor: 2.587

2.  Before and after, the impact of available on-demand treatment for HAE.

Authors:  Sandra C Christiansen; Anette Bygum; Aleena Banerji; Paula Busse; Henry Li; William Lumry; Mark Davis-Lorton; Jonathan A Bernstein; Michael M Frank; Anthony Castaldo; Janet F Long; Marc Riedl; Bruce L Zuraw
Journal:  Allergy Asthma Proc       Date:  2015 Mar-Apr       Impact factor: 2.587

Review 3.  Quality of life in patients with urticaria and angioedema: assessing burden of disease.

Authors:  David Weldon
Journal:  Allergy Asthma Proc       Date:  2014 Jan-Feb       Impact factor: 2.587

4.  National estimates of emergency department visits for angioedema and allergic reactions in the United States.

Authors:  Matthew Kelly; John P Donnelly; John-Ryan McAnnally; Henry E Wang
Journal:  Allergy Asthma Proc       Date:  2013 Mar-Apr       Impact factor: 2.587

Review 5.  Allergic reactions to foods by inhalation in children.

Authors:  Salvatore Leonardi; Rossella Pecoraro; Martina Filippelli; Michele Miraglia del Giudice; Gianluigi Marseglia; Carmelo Salpietro; Teresa Arrigo; Giovanna Stringari; Sonia Ricò; Mario La Rosa; Carlo Caffarelli
Journal:  Allergy Asthma Proc       Date:  2014 Jul-Aug       Impact factor: 2.587

6.  Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedema.

Authors:  Cheng Gang; Christopher J Lindsell; Joseph Moellman; Wesley Sublett; Kim Hart; Sean Collins; Jonathan A Bernstein
Journal:  Allergy Asthma Proc       Date:  2013 May-Jun       Impact factor: 2.587

7.  Oral immunotherapy for peanut allergy in clinical practice is ready.

Authors:  Lyndon E Mansfield
Journal:  Allergy Asthma Proc       Date:  2013 May-Jun       Impact factor: 2.587

8.  Oral and sublingual peanut immunotherapy is not ready for general use.

Authors:  Matthew J Greenhawt
Journal:  Allergy Asthma Proc       Date:  2013 May-Jun       Impact factor: 2.587

9.  Adverse drug effects and angioedema hospitalizations in the United States from 2000 to 2009.

Authors:  Robert Y Lin; Rozalyn J Levine; Huei Lin
Journal:  Allergy Asthma Proc       Date:  2013 Jan-Feb       Impact factor: 2.587

10.  Assessment of hereditary angioedema treatment risks.

Authors:  Shana Kalaria; Timothy Craig
Journal:  Allergy Asthma Proc       Date:  2013 Nov-Dec       Impact factor: 2.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.